![Jonathan Fleming](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonathan Fleming
Corporate Officer/Principal chez
INTELLIGENT MEDICINE ACQUISITION CORP.
Profil
Jonathan J.
Fleming was the founder of MVP Ventures, founded in 1988, where the title held was General Partner from 1988 to 1996.
Mr. Fleming is also the founder of Medica Venture Partners,QurAlis Corp.,Enclear Therapies, Inc...
Mr. Fleming is currently Chairman at Onc.ai, Inc. Mr. Fleming is Director at Continuus Pharmaceuticals, Inc. since 2014.
Mr. Fleming is Treasurer & Director at New England Healthcare Institute.
Mr. Fleming is Director at Leerink Swann Investment Trust since 1998.
Mr. Fleming is Advisor at 20.
Mr. Fleming is Advisor at Novatio Ventures.
Mr. Fleming is Managing Partner at Pimlico Pond Investments LLC.
Mr. Fleming is Advisor at Intelligent Medicine Acquisition Corp.
Former positions include President, Chief Executive Officer & Director at Q-State Biosciences, Inc. from 2015 to 2018.
Chairman at Memory Pharmaceuticals Corp.
from 1997 to 2008.
Director at IMCOR Pharmaceutical Co. in 2009.
Director at Hypnion, Inc. from 2003 to 2012.
Independent Director at Radius Health, Inc. from 2012 to 2013.
Independent Director at Xencor, Inc. from 2013 to 2015.
Director at Laboratory Partners, Inc. Director at Molecular Biometrics, Inc. Director at Dicerna Pharmaceuticals, Inc. Director at SVB Securities Holdings LLC.
Director at Avaxia Biologics, Inc. Director at Elixir Pharmaceuticals, Inc. Director at Enanta Pharmaceuticals, Inc. Director at BioProcessors Corp.
Non-Executive Director at BioSeek Plc from 2008 to 2011.
Director at Collgard Biopharmaceuticals Ltd. Director at superDimension, Inc. Director at GreenLight Biosciences, Inc. Director at RailRunner N.A., Inc. from 1999 to 2011.
Director at EightSpokes, Inc. Managing Partner at Oxford Bioscience Partners from 2010 to 2018.
Trustee at Museum of Science.
Education includes graduate degree from Princeton University and undergraduate degree from the University of California, Berkeley.
Postes actifs de Jonathan Fleming
| Sociétés | Poste | Début |
|---|---|---|
| INTELLIGENT MEDICINE ACQUISITION CORP. | Corporate Officer/Principal | - |
New England Healthcare Institute
 New England Healthcare Institute Miscellaneous Commercial ServicesCommercial Services Engages in identifying innovations that improve the quality and lower the costs of health care | Directeur/Membre du Conseil | - |
Enclear Therapies, Inc.
 Enclear Therapies, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel device-based therapies to treat patients | Fondateur | - |
Continuus Pharmaceuticals, Inc.
 Continuus Pharmaceuticals, Inc. Packaged SoftwareTechnology Services Develops continuous manufacturing software technology solutions for drug productions | Directeur/Membre du Conseil | 01/01/2014 |
Onc.ai, Inc.
 Onc.ai, Inc. Packaged SoftwareTechnology Services Develops precision oncology care management platform that aims to transform clinical decision making | Président | - |
Pimlico Pond Investments LLC | Corporate Officer/Principal | - |
20/20 HealthCare Partners LLC
 20/20 HealthCare Partners LLC Investment ManagersFinance 20/20 Healthcare Partners Invests in private companies located in the United States. The firm focuses on diagnostic imaging, medical devices, healthcare IT, biotechnology and pharmaceuticals. It participates in early stage transactions. It acts as lead investor. | Consultant / Advisor | - |
Leerink Swann Investment Trust | Directeur/Membre du Conseil | 29/11/2010 |
Novatio Ventures
 Novatio Ventures Investment ManagersFinance Novatio Ventures invests in companies located Canada, U.S., China, South Korea, and other markets. The firm focuses on companies in the filed of high-impact life science. It participates in seed and early stage capital requirements. | Consultant / Advisor | - |
Anciens postes connus de Jonathan Fleming
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Jonathan Fleming
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
36
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 36 |
|---|---|
Oxford Bioscience Partners
 Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners (OBP) focuses on investments in emerging, entrepreneurial-driven companies in the life sciences and healthcare sectors. They look for companies in the medical devices, R&D instruments and systems and therapeutics industries and for companies with breakthrough life sciences technology. The firm also invests in non-life science based technologies that have novel healthcare applications. OBP considers investments at almost any stage, but they place emphasis on early-stage opportunities. Investments range from $1 million to $10 million, but they may also make smaller seed investments in certain situations. OBP acts as the lead investor to organize an appropriate syndicate of co-investors. They consider investments in almost all geographic locations. | Finance |
IMCOR Pharmaceutical Co.
 IMCOR Pharmaceutical Co. Medical SpecialtiesHealth Technology Develops medical imaging pharmaceutical products | Health Technology |
Hypnion, Inc.
 Hypnion, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops neuroscience drugs | Commercial Services |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
Laboratory Partners, Inc.
 Laboratory Partners, Inc. Medical/Nursing ServicesHealth Services Provides clinical diagnostic testing services | Health Services |
Molecular Biometrics, Inc.
 Molecular Biometrics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops analytical methodologies for molecular diagnostic | Commercial Services |
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on discovering, developing and commercializing medicines for chronic liver diseases | Health Technology |
SVB Securities Holdings LLC
 SVB Securities Holdings LLC Regional BanksFinance Operates as a bank holding company whose subsidiary provides investment banking services | Finance |
Avaxia Biologics, Inc.
 Avaxia Biologics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Continuus Pharmaceuticals, Inc.
Continuus Pharmaceuticals, Inc. Packaged SoftwareTechnology Services Develops continuous manufacturing software technology solutions for drug productions | Technology Services |
Elixir Pharmaceuticals, Inc.
 Elixir Pharmaceuticals, Inc. Investment Trusts/Mutual FundsMiscellaneous Operates as a holding company with interest in manufacturing and developing biopharmaceutical products for the treatment of metabolic diseases | Miscellaneous |
Memory Pharmaceuticals Corp.
 Memory Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enanta Pharmaceuticals, Inc.
 Enanta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs for the treatment of viral infections and liver diseases | Health Technology |
BioProcessors Corp.
 BioProcessors Corp. Electronic Equipment/InstrumentsElectronic Technology Manufactures systems for optimizing biologic drug manufacturing | Electronic Technology |
Medica Venture Partners
 Medica Venture Partners Investment ManagersFinance Medica Ventures Partners invests in public and private companies located in Israel, Europe and the United States. The firm focuses on health care and life science technologies from medical devices to pharmaceuticals, biotech and genomics sectors. It provides financing for seed and early stage capital requirements. | Finance |
BioSeek Plc
 BioSeek Plc Miscellaneous Commercial ServicesCommercial Services Provides research services for pharmaceutical testing | Commercial Services |
Museum of Science
 Museum of Science Other Consumer ServicesConsumer Services Operates as a museum | Consumer Services |
New England Healthcare Institute
New England Healthcare Institute Miscellaneous Commercial ServicesCommercial Services Engages in identifying innovations that improve the quality and lower the costs of health care | Commercial Services |
MVP Ventures | |
Collgard Biopharmaceuticals Ltd.
 Collgard Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures tissue therapeutics | Health Technology |
20/20 HealthCare Partners LLC
20/20 HealthCare Partners LLC Investment ManagersFinance 20/20 Healthcare Partners Invests in private companies located in the United States. The firm focuses on diagnostic imaging, medical devices, healthcare IT, biotechnology and pharmaceuticals. It participates in early stage transactions. It acts as lead investor. | Finance |
superDimension, Inc.
 superDimension, Inc. Medical SpecialtiesHealth Technology Develops and markets pulmonology devices | Health Technology |
GreenLight Biosciences, Inc.
 GreenLight Biosciences, Inc. BiotechnologyHealth Technology Develops biotechnology and life sciences | Health Technology |
Leerink Swann Investment Trust | |
RailRunner N.A., Inc.
 RailRunner N.A., Inc. RailroadsTransportation Provides intermodal transportation solutions | Transportation |
EightSpokes, Inc.
 EightSpokes, Inc. Packaged SoftwareTechnology Services Develops SaaS platform for speed execution of management lifecycle | Technology Services |
Q-State Biosciences, Inc.
 Q-State Biosciences, Inc. BiotechnologyHealth Technology Develops optical electrophysiology platform for controlling and recording activity in electrically active cells | Health Technology |
QurAlis Corp.
 QurAlis Corp. Pharmaceuticals: MajorHealth Technology Develops precision medications | Health Technology |
Enclear Therapies, Inc.
Enclear Therapies, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel device-based therapies to treat patients | Health Technology |
Novatio Ventures
Novatio Ventures Investment ManagersFinance Novatio Ventures invests in companies located Canada, U.S., China, South Korea, and other markets. The firm focuses on companies in the filed of high-impact life science. It participates in seed and early stage capital requirements. | Finance |
Pimlico Pond Investments LLC | |
Onc.ai, Inc.
Onc.ai, Inc. Packaged SoftwareTechnology Services Develops precision oncology care management platform that aims to transform clinical decision making | Technology Services |
Intelligent Medicine Acquisition Corp.
 Intelligent Medicine Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
